日本語
TOP page
Published papers
Academic conference presentation
(Last updated : 2025-11-25 15:40:34)
NAKAYAMA Takayuki
Department
School of Medicine(Tokyo Women's Medical University Hospital), School of Medicine Department of Urology
Position
Assistant Professor
■
Published papers
1.
Original article
Long-term real-world outcomes of nivolumab plus ipilimumab for advanced renal cell carcinoma: a minimum of 4-years follow-up study. 2025/09
2.
Original article
Effect of age on treatment outcomes of first-line immune checkpoint inhibitor combination therapy for previously untreated advanced renal cell carcinoma. 2025/08
3.
Other
Impact of body composition on outcomes of immune checkpoint inhibitor combination therapy in patients with previously untreated advanced renal cell carcinoma. 2025/05
4.
Original article
Prognostic impact of the administration of antibiotics and proton pump inhibitors in immune checkpoint inhibitor combination therapy for advanced renal cell carcinoma. 2024/07/03
5.
Original article
Survival impact of glucocorticoid administration for adverse events during immune checkpoint inhibitor combination therapy in patients with previously untreated advanced renal cell carcinoma. 2024/07
6.
Case report
Advanced renal cell carcinoma with Inferior vena cava thrombus treated with a combination of preoperative lenvatinib and pembrolizumab. 2024/03
Display 5 items
Display all(6)
■
Academic conference presentation
1.
Immunotherapy outcomes and immune microenvironment profiles of patients with non-clear cell renal cell carcinoma. (ポスター掲示,一般) 2025/09/26
2.
Impact of body composition on outcomes of immune checkpoint inhibitor combination therapy in patients with previously untreated advanced renal cell carcinoma. (ポスター掲示,一般) 2025/04/27
3.
Primary renal tumor response in patients treated with first-line systemic therapy for advanced renal cell carcinoma. (ポスター掲示,一般) 2024/04/26